Skip to content
10-K

Annual Report

Provention Bio, Inc.

0001493152-23-009516

← back to feed
Filed
Mar 29, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 20, 2023 94.78M sh
Capex FY 2022 · Dec 31, 2022 $795K
Capex FY 2022 · Dec 31, 2021 $961K
Capex FY 2022 · Dec 31, 2020 $1.11M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$75.41M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$95.39M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$76.34M
Long Term Debt FY 2022 · Dec 31, 2022 $23.47M
Cash And Equivalents FY 2022 · Dec 31, 2022 $44.04M
Cash And Equivalents FY 2022 · Dec 31, 2021 $78.19M
Stockholders Equity FY 2022 · Dec 31, 2022 $121.85M
Stockholders Equity FY 2022 · Dec 31, 2021 $110.73M
Stockholders Equity FY 2022 · Dec 31, 2020 $111.07M
Stockholders Equity FY 2022 · Dec 31, 2019 $82.16M
Current Liabilities FY 2022 · Dec 31, 2022 $90.39M
Current Liabilities FY 2022 · Dec 31, 2021 $22.79M
Total Liabilities FY 2022 · Dec 31, 2022 $115.01M
Total Liabilities FY 2022 · Dec 31, 2021 $24.89M
Current Assets FY 2022 · Dec 31, 2022 $174.65M
Current Assets FY 2022 · Dec 31, 2021 $101.1M
Total Assets FY 2022 · Dec 31, 2022 $236.86M
Total Assets FY 2022 · Dec 31, 2021 $135.62M
Eps Basic FY 2022 · Dec 31, 2022 −$1.52
Eps Basic FY 2022 · Dec 31, 2021 −$1.81
Eps Basic FY 2022 · Dec 31, 2020 −$1.88
Sga Expense FY 2022 · Dec 31, 2022 $64.11M
Sga Expense FY 2022 · Dec 31, 2021 $47.35M
Sga Expense FY 2022 · Dec 31, 2020 $33.33M
Rd Expense FY 2022 · Dec 31, 2022 $75.8M
Rd Expense FY 2022 · Dec 31, 2021 $69.63M
Rd Expense FY 2022 · Dec 31, 2020 $66.36M
Net Income FY 2022 · Dec 31, 2022 −$113.57M
Net Income FY 2022 · Dec 31, 2021 −$114.43M
Net Income FY 2022 · Dec 31, 2020 −$98.58M
Operating Income FY 2022 · Dec 31, 2022 −$128.16M
Operating Income FY 2022 · Dec 31, 2021 −$115.58M
Operating Income FY 2022 · Dec 31, 2020 −$99.69M
Revenue FY 2022 · Dec 31, 2022 $12.9M
Revenue FY 2022 · Dec 31, 2021 $1.4M